Unknown

Dataset Information

0

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.


ABSTRACT: Despite high cure rates in classic Hodgkin lymphoma (cHL), relapses are observed. Whether relapsed cHL represents second primary lymphoma or an underlying T-cell lymphoma (TCL) mimicking cHL is underinvestigated. To analyze the nature of cHL recurrences, in-depth clonality testing of immunoglobulin (Ig) and T-cell receptor (TCR) rearrangements was performed in paired cHL diagnoses and recurrences among 60 patients, supported by targeted mutation analysis of lymphoma-associated genes. Clonal Ig rearrangements were detected by next-generation sequencing (NGS) in 69 of 120 (58%) diagnoses and recurrence samples. The clonal relationship could be established in 34 cases, identifying clonally related relapsed cHL in 24 of 34 patients (71%). Clonally unrelated cHL was observed in 10 of 34 patients (29%) as determined by IG-NGS clonality assessment and confirmed by the identification of predominantly mutually exclusive gene mutations in the paired cHL samples. In recurrences of >2 years, ∼60% of patients with cHL for whom the clonal relationship could be established showed a second primary cHL. Clonal TCR gene rearrangements were identified in 14 of 125 samples (11%), and TCL-associated gene mutations were detected in 7 of 14 samples. Retrospective pathology review with integration of the molecular findings were consistent with an underlying TCL in 5 patients aged >50 years. This study shows that cHL recurrences, especially after 2 years, sometimes represent a new primary cHL or TCL mimicking cHL, as uncovered by NGS-based Ig/TCR clonality testing and gene mutation analysis. Given the significant therapeutic consequences, molecular testing of a presumed relapse in cHL is crucial for subsequent appropriate treatment strategies adapted to the specific lymphoma presentation.

SUBMITTER: van Bladel DAG 

PROVIDER: S-EPMC10558751 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.

van Bladel Diede A G DAG   Stevens Wendy B C WBC   Kroeze Leonie I LI   de Groen Ruben A L RAL   de Groot Fleur A FA   van der Last-Kempkes Jessica L M JLM   Berendsen Madeleine R MR   Rijntjes Jos J   Luijks Jeroen A C W JACW   Bonzheim Irina I   van der Spek Ellen E   Plattel Wouter J WJ   Pruijt Johannes F M JFM   de Jonge-Peeters Susan D P W M SDPWM   Velders Gerjo A GA   Lensen Chantal C   van Bladel Esther R ER   Federmann Birgit B   Hoevenaars Brigiet M BM   Pastorczak Agata A   van der Werff Ten Bosch Jutte J   Vermaat Joost S P JSP   Nooijen Peet T G A PTGA   Hebeda Konnie M KM   Fend Falko F   Diepstra Arjan A   van Krieken J Han J M JHJM   Groenen Patricia J T A PJTA   van den Brand Michiel M   Scheijen Blanca B  

Blood advances 20231001 19


Despite high cure rates in classic Hodgkin lymphoma (cHL), relapses are observed. Whether relapsed cHL represents second primary lymphoma or an underlying T-cell lymphoma (TCL) mimicking cHL is underinvestigated. To analyze the nature of cHL recurrences, in-depth clonality testing of immunoglobulin (Ig) and T-cell receptor (TCR) rearrangements was performed in paired cHL diagnoses and recurrences among 60 patients, supported by targeted mutation analysis of lymphoma-associated genes. Clonal Ig r  ...[more]

Similar Datasets

| S-EPMC2700327 | biostudies-literature
| S-EPMC10660107 | biostudies-literature
| S-EPMC11369618 | biostudies-literature
| S-EPMC10821973 | biostudies-literature
| S-EPMC10038261 | biostudies-literature
2023-07-03 | GSE218703 | GEO
2023-07-03 | GSE227013 | GEO
| S-EPMC6913152 | biostudies-literature
| S-EPMC9701622 | biostudies-literature
| S-EPMC6850552 | biostudies-literature